| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Ignorance, Greed, Fear and Hope |
|
Answers - Ignorance, Greed, Fear and Hope
In the book "Reminiscences of a Stock Operator," Edwin Lefevre writes: "The speculator's deadly enemies are: Ignorance, Greed, Fear and Hope." In today's commentary we will take a look at "Ho According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product pe" and see why it is one of the four deadly enemies of successful market timing. Each of us has a desire for success. That is why we use market timing in our investing. Not only to increase o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r gains in both bull and bear markets, but importantly to protect our capital against loss. But that same desire for success can stand in the way of our ability to recognize reality, even if i lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. is right before our eyes. All of us have a survival instinct that typically causes us to focus on good news. Bad news is avoided, or at least put on the back burner. When we take a position i here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe n the market, whether bullish or bearish, we hope it will be successful. Hope can be such a powerful emotion, that when the same trading plan that told us to enter a position originally, revers d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s and tells us to exit immediately, our emotions may very well focus on the possibility that if we just hold on a bit longer, any loss may be erased. Just give it another day. Just wait till i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc is back to break even. The only way to avoid this is to recognize that hope can destroy our ability to effectively market time the markets. Hope vs. A Plan We all know that no person (trade easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi r, market timer) will be right all the time. Knowing this, we must accept that we will have losses. Trading cannot be successful without a plan. Trading by emotions, by news events, or out of nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ear, is not very different than gambling. Successful market timers win because they follow a plan. Unemotional and with clear buy and sell signals. What separates the winning traders, from the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ losing traders is their ability to recognize that when a trade turns bad, there is no emotion that can fix it. The only correct decision, is not really a decision at all. Just follow the "plan. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi If the plan says reverse, then follow it. If the plan says to go to cash, then go to cash. Simple? Nope, not if you cannot accept a loss. Then hope springs eternal (excuse the pun). Winning t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a raders have their share of losses. But they keep the amount of those losses small. They follow their plan and "never" hold onto a position "hoping" it will turn into a winner. Hope vs. Gamblin dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod When we go to las Vegas, we know that the odds are stacked in favor of the house. But we gamble anyway in "hopes" that we will leave a winner. But market timing is not gambling. When you tra cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e with a plan you have an edge that you know will win over time, as long as you use discipline and follow it. Just as the house knows it will win over time in Las Vegas, the trading plan provid tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen es the edge that makes us winners. It separates us from the urges that turn winning trades into losing ones. But once we start hoping, we lose that edge. We become just like the gamblers in Ve t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel as. And in Vegas, the house always wins. Hope vs. Ego Hope is also closely tied to ego. We do not want to admit that we have made a mistake. Our ego wants success, and wants it immediately. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Losses do not feel very successful. Our ego can cost us a great deal of money. In order to make money, we need to keep losses small, while letting our winning positions run. Neither hope nor e y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products go has any place in market timing. Neither hope nor ego has any place in making trading decisions. Conclusion When you trade with a plan, it is in black and white. It has no emotions attached . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de to it and thus the signals are not swayed by emotions. A plan does not rely on hope. A plan has no ego. A plan gives us, as market timers, an edge over the market. Each day we should examine o elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip rselves. If we feel that hope is part of our trading plan, remember that hope is almost a guarantee of losses. The only way we keep our "edge" over the stock market, is when we follow the plan tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|